CBD’s GRAS status denied: FDA emits further warnings on compound’s legality amid safety concerns

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

03 Dec 2019 --- US-based beverage brand mood33 has launched a line of hemp-infused herbal teas that contain organic, US-grown, full-spectrum hemp extract, premium botanicals and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Nov 2019 --- Canapure, Symrise’s new active cannabidiol (CBD) ingredient is the latest addition to the company’s product portfolio of approved ingredients. According... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Nov 2019 --- Cannabidiol (CBD) obtained by “synthetic means” is now excluded from the US Controlled Substance Act (CSA) regulatory controls, as long as it contains... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Nov 2019 --- This week, nutraceutical company ChromaDex received European Commission approval for listing nicotinamide riboside chloride (NR) as a novel food ingredient. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Nov 2019 --- Delivering 20 ml cannabidiol (CBD) per serving, Nuriv’s new CBD oral formulations will join its range of stand-alone CBD products. The offerings contain a... Read More

trans